PEGASPARGASE - INJECTION
PHONETIC PRONUNCIATION: (peg-ASP-are-gace)
COMMON BRAND NAME(S): Oncaspar
GENERIC NAME(S): pegaspargase
Uses
USES: This medication is usually used with other anti-cancer (chemotherapy) drugs to treat acute lymphocytic leukemia (ALL), especially in patients who are allergic to L-asparaginase. It works by starving tumor cells of a certain amino acid (asparagine), causing the tumor cells to die.
How to use PEGASPARGASE - INJECTION
HOW TO USE: This medication is given by injection into a vein or a muscle by a health care professional. Dosage is based on your body size and response to treatment.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for PEGASPARGASE - INJECTION
PEGASPARGASE is an injectable medication used to treat acute lymphoblastic leukemia (ALL), a type of cancer that affects the white blood cells.
PEGASPARGASE works by breaking down the amino acid asparagine, which cancer cells need to grow and survive. By reducing the levels of asparagine in the body, PEGASPARGASE helps to inhibit the growth of leukemia cells.
PEGASPARGASE is given as an injection into a muscle or vein by a healthcare professional. The specific dosage and frequency of administration will depend on the patient's condition and the treatment plan prescribed by their doctor.
Common side effects of PEGASPARGASE may include nausea, vomiting, abdominal pain, diarrhea, fever, rash, headache, fatigue, loss of appetite, and changes in blood clotting. It is important to report any severe or persistent side effects to a healthcare provider.
PEGASPARGASE should not be used in patients with a history of allergic reactions to this medication or any of its components. It is also important to inform the healthcare provider about any other medications, vitamins, or herbal supplements being taken as they may interact with PEGASPARGASE.
The duration of PEGASPARGASE treatment will vary depending on the individual patient and their response to therapy. It is typically given as part of a combination chemotherapy regimen, and the overall treatment duration will be determined by the treating physician.
The use of PEGASPARGASE during pregnancy or breastfeeding should be discussed with a healthcare provider. It is important to consider the potential risks and benefits of treatment in these situations.
If a dose of PEGASPARGASE is missed, it is important to contact the healthcare provider for further instructions. It is generally not recommended to administer a double dose to make up for a missed one.
PEGASPARGASE should be stored according to the instructions provided by the pharmacist or healthcare provider. It is usually stored in a refrigerator, but should not be frozen. Always check the expiration date before using the medication.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet